New Research Poster Presentation 4.31
Pharmacokinetic and Safety Evaluation of Lurasidone in Pediatric Patients With Psychiatric Disorders
Friday, October 24, 2014 9:30 AM
Robert L. Findling, MD, MBA, Department of Psychiatry, The Johns Hopkins University and Kennedy Kreiger Institute, Baltimore, MD
Yu-Yuan Chiu, PhD, Sunovion Pharmaceuticals Inc., Fort Lee, NJ
Robert Silva, PhD, Sunovion Pharmaceuticals Inc., Fort Lee, NJ
Robert Goldman, PhD, Sunovion Pharmaceuticals Inc., Fort Lee, NJ
Fengbin Jin, PhD, Sunovion Pharmaceuticals Inc., Fort Lee, NJ
Antony Loebel, MD, Sunovion Pharmaceuticals Inc., Fort Lee, NJ
